Harvard University
Cambridge, Massachusetts, 02138, United States
NCT Number: NCT03153904
Connecticut Child STEPS is a randomized controlled trail investigating the effectiveness of MATCH-ADTC in treating anxiety, depression, trauma, and/or behavioral problems in children seeking services at four Department of Children and Families (DCF) funded clinics in the state of Connecticut. The study will evaluate child outcomes following two forms of therapist training in the MATCH model.
Looking for future studies?
Notify Me7 year–15 year
All sexes
Interventional
Not applicable
Cambridge, Massachusetts, 02138, United States
This randomized controlled trial (RCT) will investigate the effectiveness of a modular, transdiagnostic treatment protocol for youth with anxiety, depression, trauma, and/or behavioral problems (MATCH-ADTC) in four DCF funded clinics in the state of Connecticut. MATCH synthesizes common elements found across dozens of evidence-based treatments into one model that is flexible and responsive to the complex needs of children and families. The RCT will evaluate child outcomes following two forms of therapist training in the MATCH model: (1) the 6-day MATCH training only; (2) the 6-day MATCH training plus weekly ongoing case consultation with a MATCH consultant. Participating children are between the ages of 7 and 15.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
MATCH-ADTC (Chorpita & Weisz, 2009) is designed for children aged 6-15. Unlike most evidence-based treatments (EBTs), which focus on single disorder categories (e.g., anxiety only), MATCH is designed for multiple disorders and problems encompassing anxiety, depression, post-traumatic stress, and disruptive conduct, including the conduct problems associated with ADHD. MATCH is composed of 33 modules-i.e., specific treatment procedures derived from decades of research on EBTs. The various modules can be organized and sequenced flexibly to tailor treatment to each child's characteristics and needs.
Other names: MATCH, MATCH - ADTC
For each child, the web-based MFS provides weekly monitoring of the MATCH modules used and the child's treatment response, in two forms (a) changes on the Brief Problem Monitor (BPM) and (b) changes in severity of the top treatment concerns identified by youths and caregivers. At the end of treatment, the MFS provides a complete record of modules used, and child treatment response, across all weeks of treatment.
Other names: MFS
Time frame: Weekly from baseline to the end of treatment, and every three months therafter until 18 month follow-up
Time frame: Weekly from baseline to the end of treatment, and every three months therafter until 18 month follow-up
Time frame: Change over time from Day 1 to end of treatment, an average of 22 weeks after baseline
Time frame: Post-treatment, an average of 22 weeks after baseline
Time frame: Change over time from Day 1 to 18 month follow-up
Time frame: Post-treatment, an average of 22 weeks after baseline
Time frame: Change over time from Day 1 to 18 month follow-up
Time frame: Post-treatment, an average of 22 weeks after baseline
Time frame: Post-treatment, an average of 22 weeks after baseline
Harvard University
Other
Child STEPs for Youth Mental Health in Connecticut
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02877875
Anxiety, Anxiety Disorders
Cambridge, Massachusetts, United States
View Trial DetailsNCT03112265
Anxiety, Anxiety Disorders
Cambridge, Massachusetts, United States
View Trial DetailsNCT03112304
Anxiety, Anxiety Disorders
Cambridge, Massachusetts, United States
View Trial DetailsNCT04725721
Anxiety, Anxiety Disorders
Cambridge, Massachusetts, United States
View Trial Details